Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Trials & Filings in Brief: Jan. 13, 2014 | Contract Pharma

What are you searching for?

Sign in
Breaking News, Trials & Filings

Trials & Filings in Brief: Jan. 13, 2014

Ampio, Galectin, Generex, Gilead, Merck, The Medicines Company

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase I
Galectin completes enrollment in first NASH cohort . . . read more

Phase II
Generex completes breast cancer immunotherapy enrollment . . . read more

Phase III
Ampio begins dosing in pivotal trial . . . read more

Filings
Gilead gets PDUFA date for iNHL treatment . . . read more

Merck begins rolling BLA for PD-1 immunotherapy . . . read more

TMC antibiotic gets QIDP designation . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics